Related references
Note: Only part of the references are listed.Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection
Joseph F. Perez-Rogers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
Gunter Weiss et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection
Joseph F. Perez-Rogers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study
Majda Haznadar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer
Angel Diaz-Lagares et al.
CLINICAL CANCER RESEARCH (2016)
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening
Hormuzd A. Katki et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Predicting Malignant Nodules from Screening CT Scans
Samuel Hawkins et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Biomarker development in the precision medicine era: lung cancer as a case study
Ashley J. Vargas et al.
NATURE REVIEWS CANCER (2016)
Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy
Duncan H. Whitney et al.
BMC MEDICAL GENOMICS (2015)
Management of Pulmonary Nodules by Community Pulmonologists A Multicenter Observational Study
Nichole T. Tanner et al.
CHEST (2015)
miR-Test: A Blood Test for Lung Cancer Early Detection
Francesca Montani et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Validation of a Multiprotein Plasma Classifier to Identify Benign Lung Nodules
Anil Vachani et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer
Gerard A. Silvestri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
Stefano Sestini et al.
ONCOTARGET (2015)
miR-Test: A Blood Test for Lung Cancer Early Detection
Francesca Montani et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Fifty Years of Tobacco Carcinogenesis Research: From Mechanisms to Early Detection and Prevention of Lung Cancer
Stephen S. Hecht et al.
CANCER PREVENTION RESEARCH (2014)
Use of Lung Cancer Screening Tests in the United States: Results from the 2010 National Health Interview Survey
V. Paul Doria-Rose et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer
Sharon R. Pine et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cumulative Incidence of False-Positive Test Results in Lung Cancer Screening A Randomized Trial
Jennifer M. Croswell et al.
ANNALS OF INTERNAL MEDICINE (2010)
Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium
Xiaoling Zhang et al.
PHYSIOLOGICAL GENOMICS (2010)
The Field of Tissue Injury in the Lung and Airway
Katrina Steiling et al.
CANCER PREVENTION RESEARCH (2008)
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer
Avrum Spira et al.
NATURE MEDICINE (2007)